Tag Archives: HIV

Caution and ideas for covering HIV/AIDS in 2019

Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

In April 1984, then-U.S. Health and Human Services Secretary Margaret Heckler announced the National Cancer Institute had discovered the virus that caused acquired immune deficiency syndrome (AIDS), and scientists hoped to soon have a cure.

Since the epidemic began, around 35 million people have died around the world from AIDS-related illnesses, and there is still no widely available cure. There have, however, been huge advances in treatment, with new drugs to prevent the disease and drugs that enable those diagnosed with the virus -human immunodeficiency virus or HIV – that causes AIDS, to live into their 70s. Continue reading

Investigations put focus on infection control in dental offices

Mary Otto

About Mary Otto

Mary Otto, a Washington, D.C.-based freelancer, is AHCJ's topic leader on oral health and the author of "Teeth: The Story of Beauty, Inequality, and the Struggle for Oral Health in America." She can be reached at mary@healthjournalism.org.

Photo: John Ong via Flickr

Two high-profile safety breaches have highlighted the importance of close adherence to infection control protocols in dental clinics and offices.

In both recent cases, patients have been advised to undergo testing for HIV and hepatitis B and C due to possible exposure to bloodborne pathogens.

In Seattle and nearby Vashon Island, news broke in early April that nearly 1,300 students face infection risks because equipment used in school clinics was improperly sterilized. Ten school-based dental clinics operated by Neighborcare, a local health center have been impacted by the safety breach. Continue reading

Advice from a reporter experienced in interviewing people in stigmatized populations

Emily Willingham

About Emily Willingham

Emily Willingham (@ejwillingham) is AHCJ's core topic leader on the social determinants of health. She is a science journalist whose work has appeared in the Washington Post, San Francisco Chronicle, Wall Street Journal, Scientific American, and Forbes, among others, and co-author of "The Informed Parent: A Science-Based Guide to Your Child's First Four Years."

Heather Boerner’s October 2018 piece at NPR examined the fate of people who live without treatment for their HIV after they leave prison. The piece was pinned to a study published in PLOS One showing that people with HIV often are lost to care once they leave the monitoring and services provided in prison.

In her article, in addition to providing an in-depth perspective from several experts, Boerner also gave the reader the story of Bryan C. Jones, who had left a prison in Ohio and almost immediately ditched his HIV drugs because he knew they were no longer working. Continue reading

Connecting the dots between social determinants and infectious diseases

Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Neil Moralee via Flickr

Socioeconomic factors such as poverty and living conditions play a role in shaping infection risk and disease outcomes.

Many times people in poverty live in crowded conditions, have limited access to quality health care, must work when they are sick, eat less nutritiously, get less sleep, face more stress and are more likely than others to abuse drugs and alcohol. All of these factors hinder immunity and increase susceptibility to infection and death. Continue reading

Infectious disease outbreaks rise with opioid epidemic

Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Photo: Courtesy of the San Diego Union TribuneTent “cities” have swelled in southern California, creating crowded and unsanitary conditions.

Cases of infectious diseases such as hepatitis A, B and C, sexually transmitted diseases (STDs) and human immunodeficiency virus (HIV) have surged as the opioid epidemic has worsened over the past several years, two public health officials said during a Aug. 23 webcast for AHCJ members.

The increasing number of infectious disease cases are likely due to infected needle injections, unprotected sex, homelessness, lack of access to medical care and other socioeconomic challenges associated with people who have physical addictions to drugs and opioids.

Continue reading

Covering HIV in the modern era: What reporters need to know

Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Image: Benny Sølz via Flickr

About 36.7 million people around the world – about 1.1 million in the U.S.- are living with an HIV (human immunodeficiency virus) diagnosis, making it one of the most enduring pandemics on the planet. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). Since the virus was first discovered in the 1980s, about 35 million people have died from complications of AIDS.

There has been much progress in terms of treatment. There are now 30 antiretroviral drugs available for those diagnosed with HIV, writes Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Disease, in the JAMA Network. Continue reading